483 Nesher Pharmaceuticals (USA) Jul 2018

483 Nesher Pharmaceuticals (USA) Jul 2018

Yaodong Huang FDA, Andrew Idzior FDA, Michele Perry-Williams FDA$119.00 - Available Now

FDA investigators audited the Nesher Pharmaceuticals (USA) - Bridgeton, MO, United States facility and issued inspectional observations (via FDA 483) on 18 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Jul 2018
  • Location: Bridgeton, United States
  • FEI: 1922352
Add To Cart